Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.12 USD | +0.62% | -2.18% | -11.96% |
14/05 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
10/05 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.96% | 6.15B | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-09-2021 01